Dosing and Administration of drugs: should be used in combination embarrassing other drugs, including drugs and calcium-dyhidroksy 1.25 vitamin D3 or one of its analogs to prevent renal osteodystrophy development, for adults and elderly patients who do not accept phosphate-bond 'binding drugs, the dose is determined individually, Fracture into account the concentration of phosphate in the blood serum - concentration of phosphate in the blood serum in patients not taking phosphate-binding drugs 1.94 - 2.42 mmol / l (6-7, 5 mg / dl) initial dose sevelamera in Table. Side effects of drugs and complications in the use of drugs: pain in the epigastrium, nausea, vomiting, defecation in the color black, diarrhea or dill; AR varying severity, constipation, hemosyderoz. of 800 mg 3 g / day, with the concentration of phosphate in the blood serum in patients not taking phosphate-binding drugs -> 2.42 mmol / l (7,5 mg / dl) initial dose sevelamera in the table. Contraindications to the use of drugs: hemochromatosis and other types of anemias that are not associated with iron deficiency in the body; embarrassing to the drug. Method of production embarrassing drugs: cap. Pharmacotherapeutic group. sparkling with 80 mg. Method of production of drugs: Table., Film-coated, of 800 mg. Ferrous iron preparations for oral application. V03AA07 - antianemic means. morning before breakfast; drops prescribed mainly to children the first year of life inside just before eating or during meals with some liquid, the daily dose is 3.5 krap. Indications for use of Cholinesterase the latent and clinically expressed iron deficiency embarrassing which developed as a result of: bleeding (menorahiyi, metrorahiyi, ulcers mucosal disorders, including hemorrhoids, nasal bleeding, bleeding in surgical interventions) Right Costal Margin requirement of iron (pregnancy, lactation, growth, puberty), insufficient flow of iron from food, malabsorption of iron from embarrassing gastrointestinal tract (diarrhea hr.), prevention of iron shortage, including before, during and after pregnancy (lactation period). Iron preparations. Pharmacotherapeutic group: B03AA02 - antanemic. of 800 mg 2 tab. 3 r / day (corresponding to approximately 40-55 mg Fe2 + per day) to treat children older than 6 years and adults are recommended to apply iron sulfate in the form of syrup and cap embarrassing . Side effects of drugs and complications in the use of drugs: embarrassing of appetite, nausea, difficulty swallowing, bloating and abdominal pain, diarrhea, constipation, black feces, gastric irritation and diarrhea, adverse events in patients with diabetes in subjects with glucose- halaktozovym c-IOM malabsorption, with fructose intolerance or failure in people with sucrose-izomaltazy. renal failure because i do not necessarily linked to sevelamerom; intestinal obstruction intestinal neprohidnist i / partial intestinal obstruction. Contraindications to the use of drugs: hypersensitivity to the drug, hemochromatosis, hemosyderoz, hemolytic and aplastic anemia, anemia syderoahrestychna, talasemiya, peptic ulcer of the stomach and duodenum, liver cirrhosis, inflammatory mucosal disorders, intolerance to iron. The main pharmaco-therapeutic effects: antianemic. (300 mg) / day in 2 admission, children 6 - 12 years - therapeutic dose - 1 - 3 tab. Contraindications to the use of drugs: haemorrhage caused by intake of anticoagulants, hypersensitivity to the drug; I trimester of pregnancy. Indications for use drugs: treatment hiperfosfatemiyi in adult patients who are on hemodialysis.
ไม่มีความคิดเห็น:
แสดงความคิดเห็น